"Macula Lutea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. (From Cline et al., Dictionary of Visual Science, 4th ed)
- Macula Lutea
- Lutea, Macula
- Luteas, Macula
- Macula Luteas
Below are MeSH descriptors whose meaning is more general than "Macula Lutea".
Below are MeSH descriptors whose meaning is more specific than "Macula Lutea".
This graph shows the total number of publications written about "Macula Lutea" by people in this website by year, and whether "Macula Lutea" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Macula Lutea" by people in Profiles.
Cheng SY, Cipi J, Ma S, Hafler BP, Kanadia RN, Brush RS, Agbaga MP, Punzo C. Altered photoreceptor metabolism in mouse causes late stage age-related macular degeneration-like pathologies. Proc Natl Acad Sci U S A. 2020 06 09; 117(23):13094-13104.
Birch DG, Benz MS, Miller DM, Antoszyk AN, Markoff J, Kozma P, Meunier E, Sergott RC. EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy. Retina. 2018 Feb; 38(2):364-378.
Nesmith BL, Palacio AC, Schaal Y, Gupta A, Schaal S. DIABETES ALTERS THE MAGNITUDE OF VITREOMACULAR ADHESION. Retina. 2017 Apr; 37(4):749-752.
Palacio AC, Gupta A, Nesmith BL, Jadav PR, Schaal Y, Schaal S. VITREOMACULAR ADHESION EVOLUTION WITH AGE IN HEALTHY HUMAN EYES. Retina. 2017 Jan; 37(1):118-123.
Seddon JM, Silver RE, Kwong M, Rosner B. Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates. Invest Ophthalmol Vis Sci. 2015 Apr; 56(4):2192-202.
Piri N, Nesmith BL, Schaal S. Choroidal hyperreflective foci in Stargardt disease shown by spectral-domain optical coherence tomography imaging: correlation with disease severity. JAMA Ophthalmol. 2015 Apr; 133(4):398-405.
Szelog JT, Lally DR, Heier JS. Natural history of Valsalva-induced subhyaloid hemorrhage. JAMA Ophthalmol. 2015 Feb; 133(2):e143268.
Rifkin L, Schaal S. Teenage acute macular neuroretinopathy. Eur J Ophthalmol. 2012 Jul-Aug; 22(4):674-6.
Jun JJ, Duker JS, Baumal CR, McCabe F, Reichel E, Rogers AH, Seddon JM, Tolentino FI. Cystoid macular edema without macular thickening: a retrospective optical coherence tomographic study. Retina. 2010 Jun; 30(6):917-23.
Edwards AO, Swaroop A, Seddon JM. Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med. 2009 May 21; 360(21):2254-5; author reply 2255-6.